Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:17-24
Published online before print June 18, 2007, doi: 10.1161/CIRCULATIONAHA.107.708818
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/1/17    most recent
CIRCULATIONAHA.107.708818v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gong, Q.
Right arrow Articles by Zhou, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gong, Q.
Right arrow Articles by Zhou, Z.
Related Collections
Right arrow Arrythmias-basic studies

(Circulation. 2007;116:17-24.)
© 2007 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Nonsense Mutations in hERG Cause a Decrease in Mutant mRNA Transcripts by Nonsense-Mediated mRNA Decay in Human Long-QT Syndrome

Qiuming Gong, MD, PhD; Li Zhang, MD; G. Michael Vincent, MD; Benjamin D. Horne, PhD, MPH; Zhengfeng Zhou, MD, PhD

From the Division of Cardiovascular Medicine, Department of Medicine, Oregon Health and Science University, Portland (Q.G., Z.Z.); and Departments of Medicine and Cardiology (L.Z., G.M.V.) and Genetic Epidemiology Division (B.D.H.), LDS Hospital, Intermountain Healthcare and University of Utah, Salt Lake City.

Correspondence to Dr Zhengfeng Zhou, Division of Cardiovascular Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239. E-mail zhouzh{at}ohsu.edu

Received October 26, 2006; accepted May 8, 2007.

Background— Long-QT syndrome type 2 (LQT2) is caused by mutations in the human ether-a-go-go-related gene (hERG). More than 30% of the LQT2 mutations result in premature termination codons. Degradation of premature termination codon–containing mRNA transcripts by nonsense-mediated mRNA decay is increasingly recognized as a mechanism for reducing mRNA levels in a variety of human diseases. However, the role of nonsense-mediated mRNA decay in LQT2 mutations has not been explored.

Methods and Results— We examined the expression of hERG mRNA in lymphocytes from patients carrying the R1014X mutation using a technique of allele-specific transcript quantification. The R1014X mutation led to a reduced level of mutant mRNA compared with that of the wild-type allele. The decrease in mutant mRNA also was observed in the LQT2 nonsense mutations W1001X and R1014X using hERG minigenes expressed in HEK293 cells or neonatal rat ventricular myocytes. Treatment with the protein synthesis inhibitor cycloheximide or RNA interference–mediated knockdown of the Upf1 protein resulted in the restoration of mutant mRNA to levels comparable to that of the wild-type minigene, suggesting that hERG nonsense mutations are subject to nonsense-mediated mRNA decay.

Conclusions— These results indicate that LQT2 nonsense mutations cause a decrease in mutant mRNA levels by nonsense-mediated mRNA decay rather than production of truncated proteins. Our findings suggest that the degradation of hERG mutant mRNA by nonsense-mediated mRNA decay is an important mechanism in LQT2 patients with nonsense or frameshift mutations.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
W. Shimizu, A. J. Moss, A. A.M. Wilde, J. A. Towbin, M. J. Ackerman, C. T. January, D. J. Tester, W. Zareba, J. L. Robinson, M. Qi, et al.
Genotype-Phenotype Aspects of Type 2 Long QT Syndrome
J. Am. Coll. Cardiol., November 24, 2009; 54(22): 2052 - 2062.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Carrier, S. Schlossarek, M. S. Willis, and T. Eschenhagen
Ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy
Cardiovasc Res, August 10, 2009; (2009) cvp247v2.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Vignier, S. Schlossarek, B. Fraysse, G. Mearini, E. Kramer, H. Pointu, N. Mougenot, J. Guiard, R. Reimer, H. Hohenberg, et al.
Nonsense-Mediated mRNA Decay and Ubiquitin-Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice
Circ. Res., July 31, 2009; 105(3): 239 - 248.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
Y. Ruan, N. Liu, C. Napolitano, and S. G. Priori
Therapeutic Strategies for Long-QT Syndrome: Does the Molecular Substrate Matter?
Circ Arrhythm Electrophysiol, October 1, 2008; 1(4): 290 - 297.
[Full Text] [PDF]